Literature DB >> 10219896

IL-1beta, IL-6 and TNF-alpha in synovial fluid of patients with non-gonococcal septic arthritis.

M Osiri1, K Ruxrungtham, S Nookhai, Y Ohmoto, U Deesomchok.   

Abstract

Interleukin-1 beta (IL-1beta), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) are the main proinflammatory cytokines responsible for the inflammatory process and cartilage destruction of inflammatory arthropathies. The present study sequentially measured the concentrations of these cytokines and their proportions of detectable levels in the synovial fluid (SF) of 23 patients with non-gonococcal (GC) septic arthritis before and after treatment. Persistently high concentrations and proportions of IL-6 and TNF-alpha were found up to day 7 of treatment, while SF IL-1beta concentration declined significantly after day 7 (p = 0.036). SF IL-1beta and TNF-alpha correlated with each other significantly and with SF WBC counts (p < 0.01). Positive correlations between SF IL-1beta concentration and joint effusion (p < 0.01) and between SF TNF-alpha concentration and joint tenderness (p < 0.001) were observed. SF IL-1beta and TNF-alpha were significantly higher in patients with local complications of septic arthritis. In conclusion, high levels of IL-1beta, IL-6 and TNF-alpha were detected in SF of patients with non-GC septic arthritis. Only IL-1beta decreased significantly after day 7 of treatment, but IL-6 and TNF-alpha concentrations were persistently high. SF IL-1beta and TNF-alpha may be useful in predicting the outcome and complications of patients with this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10219896

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  10 in total

1.  Potential role of fibroblast-like synoviocytes in joint damage induced by Brucella abortus infection through production and induction of matrix metalloproteinases.

Authors:  Romina Scian; Paula Barrionuevo; Guillermo H Giambartolomei; Emilio A De Simone; Silvia I Vanzulli; Carlos A Fossati; Pablo C Baldi; M Victoria Delpino
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

2.  Phasevarion-Regulated Virulence in the Emerging Pediatric Pathogen Kingella kingae.

Authors:  Yogitha N Srikhanta; Ka Yee Fung; Georgina L Pollock; Vicki Bennett-Wood; Benjamin P Howden; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

3.  IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis.

Authors:  Jerod A Skyberg; Theresa Thornburg; Irina Kochetkova; William Layton; Gayle Callis; MaryClare F Rollins; Carol Riccardi; Todd Becker; Sarah Golden; David W Pascual
Journal:  J Leukoc Biol       Date:  2012-05-25       Impact factor: 4.962

Review 4.  Interaction of staphylococci with bone.

Authors:  John A Wright; Sean P Nair
Journal:  Int J Med Microbiol       Date:  2009-11-03       Impact factor: 3.473

5.  Proinflammatory response of human osteoblastic cell lines and osteoblast-monocyte interaction upon infection with Brucella spp.

Authors:  M Victoria Delpino; Carlos A Fossati; Pablo C Baldi
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

Review 6.  Acute septic arthritis.

Authors:  Mark E Shirtliff; Jon T Mader
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

7.  A novel mouse model for septic arthritis induced by Pseudomonas aeruginosa.

Authors:  Tao Jin; Majd Mohammad; Zhicheng Hu; Ying Fei; Edward R B Moore; Rille Pullerits; Abukar Ali
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

8.  Microbial determinants of arthritis.

Authors:  Shakti D Shukla; Madhur D Shastri; Niraj Kumar Jha; Kamal Dua
Journal:  EXCLI J       Date:  2020-12-09       Impact factor: 4.068

Review 9.  Bacteria and Host Interplay in Staphylococcus aureus Septic Arthritis and Sepsis.

Authors:  Tao Jin; Majd Mohammad; Rille Pullerits; Abukar Ali
Journal:  Pathogens       Date:  2021-02-03

10.  Gemcabene, a First-in-Class Hypolipidemic Small Molecule in Clinical Development, Attenuates Osteoarthritis and Pain in Animal Models of Arthritis and Pain.

Authors:  Rai A K Srivastava; Joseph A Cornicelli; Bruce Markham; Charles L Bisgaier
Journal:  Front Pharmacol       Date:  2018-05-11       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.